Optical coherence tomography has become an established method for imaging r
etinal diseases. It is now an accepted method for making quantitative measu
rements in studies on the cause and course of macular holes, vitreoretinal
traction, pigment epithelial detachment, macular edema, and diabetic retino
pathy. Its potential benefit in the evaluation of age-related macular degen
eration and a variety of other diseases is currently under investigation. I
n clinical practice optical coherence tomography images add information to
the biomicroscopic findings and results of other imaging techniques or func
tional testing and can significantly help in making critical decisions. Its
future role in routine clinical practice will depend on furth er technical
development and the results of long-term studies.